US$ 21.00
what is an alternative to glp 1 drugs A new FDA-approved obesity pill could offer a lower-cost injectable GLP-1 like Ozempic and Mounjaro. In a major clinical trial, people taking the highest dose lost about 11% of GLP-1 Drug Savings: A Complete
Description
doi: 10.2337/dc19-1892

the formed thrombus then blocks the lumen, also inducing tissue ischemia

Other ocular Issues

Some studies suggest GLP-1 receptor agonists may improve cellular energy production and reduce oxidative stress, potentially supporting neuron survival

Trulicity patients in the United States are also filing lawsuits because of injection-related complications, including vision loss and pancreatitis

In short, while retatrutide looks highly promising, careful monitoring and more data are needed before it becomes widely available
